Bullish
$IBIO Dr. James Samuel, Head of the Department of Microbial Pathogenesis and Immunology at Texas A&M University. “We look forward to completing the preclinical immunization studies for iBio ... to advance to human clinical trials.” Not far from the next phase which is injecting the first patient cdc.gov/vaccines/basics/tes...
  • 10
  • 2